tiprankstipranks
scPharmaceuticals Inc (SCPH)
NASDAQ:SCPH
US Market
Holding SCPH?
Track your performance easily

scPharmaceuticals (SCPH) Income Statement

429 Followers

scPharmaceuticals Income Statement

Last quarter (Q3 2024), scPharmaceuticals's total revenue was $10.03M, an increase of 164.12% from the same quarter last year. In Q3, scPharmaceuticals's net income was $-35.10M. See scPharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 30.28M$ 13.59M$ 47.00K$ 51.00K$ 51.00K$ 56.00K
Cost of Revenue
$ 9.17M$ 3.81M----
Gross Profit
$ 21.11M$ 9.78M$ 47.00K$ 51.00K$ 51.00K$ 56.00K
Operating Expense
$ 90.16M$ 65.18M$ 36.16M$ 25.82M$ 29.93M$ 32.91M
Operating Income
$ -63.69M$ -55.40M$ -36.16M$ -25.82M$ -29.93M$ -32.91M
Net Non Operating Interest Income Expense
$ -4.61M$ -3.02M$ -2.10M$ -2.53M$ -2.27M$ -107.00K
Other Income Expense
$ 14.24M$ 3.60M$ 1.42M$ -315.00K$ 4.00K$ -16.00K
Pretax Income
$ -75.33M$ -54.81M$ -36.84M$ -28.03M$ -32.21M$ -33.00M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -80.11M$ -54.81M$ -36.84M$ -28.03M$ -32.21M$ -33.00M
Basic EPS
$ -1.90$ -1.42$ -1.30$ -1.02$ -1.31-
Diluted EPS
$ -1.90$ -1.42$ -1.30$ -1.02$ -1.31$ -1.77
Basic Average Shares
$ 163.30M$ 38.51M$ 28.36M$ 27.35M$ 24.57M$ 18.60M
Diluted Average Shares
$ 163.30M$ 38.51M$ 28.36M-$ 24.57M$ 18.60M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 103.14M$ 68.99M$ 36.16M$ 25.82M$ 29.93M$ 32.91M
Net Income From Continuing And Discontinued Operation
$ -80.11M$ -54.81M$ -36.84M$ -28.03M$ -32.21M$ -33.00M
Normalized Income
$ -54.04M$ -39.49M-$ -22.15M--
Interest Expense
------
EBIT
$ -56.83M$ -46.69M$ -33.54M$ -25.46M$ -29.62M$ -31.23M
EBITDA
$ -56.55M$ -46.06M$ -33.07M$ -24.90M$ -29.22M$ -30.86M
Currency in USD

scPharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis